MGS
DEAD

Serial Number

97476208

Owner

Dimension Genomics Inc

Attorney

Dana Dickson

Filing Date

Jun 26, 2022

Add to watchlist:

No watchlists yet
View on USPTO

MGS Trademark

Serial Number: 97476208

MGS is a trademark filed by Dimension Genomics Inc on June 26, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Dimension Genomics Inc (4 trademarks)

4326 Falcon St
San Diego, CA 92103

Entity Type: 03

Trademark Details

Filing Date

June 26, 2022

Registration Date

Not Registered

Goods & Services

Downloadable software and software for analyzing sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for genomic research and medical research use. Microfluidic devices for the generation of sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for genomic research and medical research use. Instruments for the generation of sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for genomic research and medical research use

Reagents and kits of reagents for preparing molecules, devices, consumables, and instruments for the generation of sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for genomic research, medical research, and medical diagnostic use

Reagents and kits of reagents for preparing molecules, devices, consumables, and instruments for the generation of sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for genomic research, medical research, and medical diagnostic use

Non-Downloadable software and software-as-a-service for analyzing sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for medical diagnostic use. Medical diagnostic services, medical diagnostic testing and reporting services for the generation of sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for medical use

Downloadable software and software for analyzing sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for medical diagnostic use. Microfluidic devices for the generation of sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for medical diagnostic use. Instruments for the generation of sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for medical diagnostic use

Non-Downloadable software and software-as-a-service for analyzing sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for genomic research and medical research use. Services for the generation of sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for genomic research and medical research use

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
May 5, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 5, 2025 ABN2
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Jan 16, 2025 GNS1
CONTINUATION OF FINAL REFUSAL E-MAILED
Jan 16, 2025 GNCF
ACTION CONTINUING A FINAL - COMPLETED
Jan 16, 2025 CNCF
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 11, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 11, 2024 GNSL
SUSPENSION LETTER WRITTEN
Apr 11, 2024 CNSL
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 9, 2024 GNFN
FINAL REFUSAL E-MAILED
Apr 9, 2024 GNFR
FINAL REFUSAL WRITTEN
Apr 9, 2024 CNFR
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 10, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 10, 2023 GNSL
SUSPENSION LETTER WRITTEN
Oct 10, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 9, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 9, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 9, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 3, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 3, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 10, 2023 GNRN
NON-FINAL ACTION E-MAILED
Apr 10, 2023 GNRT
NON-FINAL ACTION WRITTEN
Apr 10, 2023 CNRT
ASSIGNED TO EXAMINER
Apr 6, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 14, 2022 NWOS
NEW APPLICATION ENTERED
Jun 29, 2022 NWAP